122 related articles for article (PubMed ID: 6436473)
1. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
Zambraski EJ; Chremos AN; Dunn MJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):560-6. PubMed ID: 6423807
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
Kitamura S; Tatsumi K
Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
5. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
[TBL] [Abstract][Full Text] [Related]
6. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
7. Effects of sulindac and indomethacin on renal prostaglandin synthesis.
Sedor JR; Williams SL; Chremos AN; Johnson CL; Dunn MJ
Clin Pharmacol Ther; 1984 Jul; 36(1):85-91. PubMed ID: 6428794
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
10. Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agent.
Miller MJ; Bednar MM; McGiff JC
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():487-91. PubMed ID: 6221568
[No Abstract] [Full Text] [Related]
11. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
12. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of graded oral doses of sulindac in man.
Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulindac on prostaglandin synthesis in human and in cultured rat renal and vascular smooth muscle cells.
Sato M; Abe K; Takeuchi K; Yasujima M; Akiu N; Saito T; Yoshinaga K
Tohoku J Exp Med; 1992 Jan; 166(1):185-200. PubMed ID: 1412444
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
Graham DY; Smith JL; Holmes GI; Davies RO
Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
[TBL] [Abstract][Full Text] [Related]
16. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl sulfoxide inhibits bioactivation of sulindac.
Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of sulindac on prostaglandin synthesis in cultured renal and vascular cells.
Sato M; Abe K; Takeuchi K; Yasujima M; Hagino T; Fang S; Kohzuki M; Yoshinaga K
Agents Actions Suppl; 1987; 22():37-42. PubMed ID: 3324718
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs.
Dunn MJ; Scharschmidt L; Zambraski E
Arch Toxicol Suppl; 1984; 7():328-37. PubMed ID: 6595999
[TBL] [Abstract][Full Text] [Related]
20. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
